Sarah Boyce - 24 Jun 2024 Form 4 Insider Report for Contineum Therapeutics, Inc. (CTNM)

Role
Director
Signature
/s/ Peter Slover, Attorney-in-Fact
Issuer symbol
CTNM
Transactions as of
24 Jun 2024
Net transactions value
$0
Form type
4
Filing time
24 Jun 2024, 16:25:48 UTC
Previous filing
21 Jun 2024
Next filing
11 Jul 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CTNM Stock Option (right to buy) Award $0 +29,500 $0.000000 29,500 24 Jun 2024 Class A Common Stock 29,500 $19.19 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Options granted under the Issuer's 2024 Equity Incentive Plan, pursuant to the Issuer's Non-Employee Director Compensation Program. One-third of the option shares vest and become exercisable on June 24, 2025, and the remainder vests in 24 equal monthly installments thereafter, subject to the Reporting Person's continuous service.

Remarks:

Exhibit 24 - Power of Attorney